Extensive lichen planopilaris as exclusive lichenoid reaction secondary to pembrolizumab in a patient with metastatic melanoma

Dermatol Ther. 2022 May;35(5):e15388. doi: 10.1111/dth.15388. Epub 2022 Feb 24.

Authors

Cristina Garcia-Melendo¹, Caridad E Morales-Munera¹, Joan Dalmau¹, Xavier Cubiró¹, Cristina López-Sánchez¹, Anna Mozos², Oriol Yélamos¹

Affiliations

¹ Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
² Department of Pathology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

PMID: 35174945
DOI: 10.1111/dth.15388

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Humans
Lichen Planus* / chemically induced
Lichen Planus* / diagnosis
Lichen Planus* / pathology
Melanoma* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab

Supplementary concepts

Lichen planus follicularis